Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared a post on X about a paper he co-authored with colleagues published in JCO Oncology Practice:
“Here’s our latest work led by Neha Venkatesh in JCO Oncology Practice.
We evaluate how cardiometabolic risk scores perform in men with localized high-risk PCa who received 6 months of pre-op ADT +/- ARPI.”
Title: Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy
Authors: Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S. Mukhida, Kabir Grewal, Ana Aparicio, Patrick G. Pilie, Sumit K. Subudhi, Paul G. Corn, Ashwin Sachdeva, Monica Desai, Bilal A. Siddiqui, Amado J. Zurita, Debanjan Pain, Justin R. Gregg, Daniel E. Frigo, Christopher J. Logothetis, Pavlos Msaouel, Efstratios Koutroumpakis, and Andrew W. Hahn
You can read the Full Article in JCO Oncology Practice.
More posts featuring Andy Hahn.
